BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 37068004)

  • 1. Cisplatin-induced ototoxicity: a novel approach to an ancient problem.
    Omar NE; Elewa H
    Pharmacogenet Genomics; 2023 Jul; 33(5):111-115. PubMed ID: 37068004
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Systematic Critical Review of Genetic Factors Associated with Cisplatin-induced Ototoxicity: Canadian Pharmacogenomics Network for Drug Safety 2022 Update.
    Scott EN; Joseph AA; Dhanda A; Tanoshima R; Brooks B; Rassekh SR; Ross CJD; Carleton BC; Loucks CM
    Ther Drug Monit; 2023 Dec; 45(6):714-730. PubMed ID: 37726872
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacogenomics of Cisplatin-Induced Ototoxicity: Successes, Shortcomings, and Future Avenues of Research.
    Drögemöller BI; Wright GEB; Lo C; Le T; Brooks B; Bhavsar AP; Rassekh SR; Ross CJD; Carleton BC
    Clin Pharmacol Ther; 2019 Aug; 106(2):350-359. PubMed ID: 31012503
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Medical interventions for the prevention of platinum-induced hearing loss in children with cancer.
    van As JW; van den Berg H; van Dalen EC
    Cochrane Database Syst Rev; 2014 Jul; (7):CD009219. PubMed ID: 24984156
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Medical interventions for the prevention of platinum-induced hearing loss in children with cancer.
    van As JW; van den Berg H; van Dalen EC
    Cochrane Database Syst Rev; 2012 May; (5):CD009219. PubMed ID: 22592737
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Otoprotective Effects of Zingerone on Cisplatin-Induced Ototoxicity.
    Lee CH; Lee DH; Lee SM; Kim ASY
    Int J Mol Sci; 2020 May; 21(10):. PubMed ID: 32429117
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aminoglycoside- and Cisplatin-Induced Ototoxicity: Mechanisms and Otoprotective Strategies.
    Kros CJ; Steyger PS
    Cold Spring Harb Perspect Med; 2019 Nov; 9(11):. PubMed ID: 30559254
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cisplatin-induced ototoxicity: Updates on molecular mechanisms and otoprotective strategies.
    Tang Q; Wang X; Jin H; Mi Y; Liu L; Dong M; Chen Y; Zou Z
    Eur J Pharm Biopharm; 2021 Jun; 163():60-71. PubMed ID: 33775853
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel synthetic protective compound, KR-22335, against cisplatin-induced auditory cell death.
    Shin YS; Song SJ; Kang S; Hwang HS; Jung YS; Kim CH
    J Appl Toxicol; 2014 Feb; 34(2):191-204. PubMed ID: 23297007
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protective effect of N-acetylcysteine against cisplatin ototoxicity in rats: a study with hearing tests and scanning electron microscopy.
    Somdaş MA; Güntürk İ; Balcıoğlu E; Avcı D; Yazıcı C; Özdamar S
    Braz J Otorhinolaryngol; 2020; 86(1):30-37. PubMed ID: 30268784
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacogenetics of drug-induced ototoxicity caused by aminoglycosides and cisplatin.
    Lanvers-Kaminsky C; Ciarimboli G
    Pharmacogenomics; 2017 Dec; 18(18):1683-1695. PubMed ID: 29173064
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Medical interventions for the prevention of platinum-induced hearing loss in children with cancer.
    van As JW; van den Berg H; van Dalen EC
    Cochrane Database Syst Rev; 2019 May; 5(5):CD009219. PubMed ID: 31063591
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Future opportunities in preventing cisplatin induced ototoxicity.
    van den Berg JH; Beijnen JH; Balm AJ; Schellens JH
    Cancer Treat Rev; 2006 Aug; 32(5):390-7. PubMed ID: 16781082
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ferrostatin-1 protects auditory hair cells from cisplatin-induced ototoxicity in vitro and in vivo.
    Hu B; Liu Y; Chen X; Zhao J; Han J; Dong H; Zheng Q; Nie G
    Biochem Biophys Res Commun; 2020 Dec; 533(4):1442-1448. PubMed ID: 33109343
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Further Investigation of the Role of
    Drögemöller BI; Brooks B; Critchley C; Monzon JG; Wright GEB; Liu G; Renouf DJ; Kollmannsberger CK; Bedard PL; Hayden MR; Gelmon KA; Carleton BC; Ross CJD
    Clin Cancer Res; 2018 Apr; 24(8):1866-1871. PubMed ID: 29358504
    [No Abstract]   [Full Text] [Related]  

  • 16. Usefulness of current candidate genetic markers to identify childhood cancer patients at risk for platinum-induced ototoxicity: Results of the European PanCareLIFE cohort study.
    Langer T; Clemens E; Broer L; Maier L; Uitterlinden AG; de Vries ACH; van Grotel M; Pluijm SFM; Binder H; Mayer B; von dem Knesebeck A; Byrne J; van Dulmen-den Broeder E; Crocco M; Grabow D; Kaatsch P; Kaiser M; Spix C; Kenborg L; Winther JF; Rechnitzer C; Hasle H; Kepak T; van der Kooi AF; Kremer LC; Kruseova J; Bielack S; Sorg B; Hecker-Nolting S; Kuehni CE; Ansari M; Kompis M; van der Pal H; Parfitt R; Deuster D; Matulat P; Tillmanns A; Tissing WJE; Beck JD; Elsner S; Am Zehnhoff-Dinnesen A; van den Heuvel-Eibrink MM; Zolk O;
    Eur J Cancer; 2020 Oct; 138():212-224. PubMed ID: 32905960
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protective role of misoprostol against cisplatin-induced ototoxicity.
    Doğan M; Polat H; Yaşar M; Kaya A; Bayram A; Şenel F; Özcan İ
    Eur Arch Otorhinolaryngol; 2016 Nov; 273(11):3685-3692. PubMed ID: 27052552
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transtympanic Injections of N-acetylcysteine and Dexamethasone for Prevention of Cisplatin-Induced Ototoxicity: Double Blind Randomized Clinical Trial.
    Sarafraz Z; Ahmadi A; Daneshi A
    Int Tinnitus J; 2018 Jun; 22(1):40-45. PubMed ID: 29993216
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic variation of cisplatin-induced ototoxicity in non-cranial-irradiated pediatric patients using a candidate gene approach: The International PanCareLIFE Study.
    Clemens E; Broer L; Langer T; Uitterlinden AG; de Vries ACH; van Grotel M; Pluijm SFM; Binder H; Byrne J; Broeder EVD; Crocco M; Grabow D; Kaatsch P; Kaiser M; Kenborg L; Winther JF; Rechnitzer C; Hasle H; Kepak T; van der Kooi AF; Kremer LC; Kruseova J; Kuehni CE; van der Pal H; Parfitt R; Deuster D; Matulat P; Spix C; Tillmanns A; Tissing WJE; Maier L; Am Zehnhoff-Dinnesen A; Zolk O; van den Heuvel-Eibrink MM;
    Pharmacogenomics J; 2020 Apr; 20(2):294-305. PubMed ID: 31666714
    [TBL] [Abstract][Full Text] [Related]  

  • 20. EPO Attenuates Cisplatin-Induced Ototoxicity in HEI-OC1 Auditory Cell Via the Nrf2-ARE Signaling Pathway.
    Sun C; Yao Y; Zhang C; Tong D; Xie B
    Otol Neurotol; 2019 Aug; 40(7):965-971. PubMed ID: 31135681
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.